Last $106.74 USD
Change Today +1.19 / 1.13%
Volume 8.1M
JNJ On Other Exchanges
Symbol
Exchange
Xetra
Mexico
Sao Paulo
Bogota
As of 4:15 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One Johnson & Johnson Plaza

New Brunswick, NJ 08933

United States

Phone: 732-524-0400

Fax:

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the health care field. The business of the company is conducted by approximately 275 operating companies located in 60 countries, including the United States, which sell products in all countries worldwide. Segments The company is organized into three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Consumer The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products and wellness and prevention platforms. The Baby Care franchise includes the JOHNSON’S Baby line of products. Major brands in the Skin Care franchise include the AVEENO; CLEAN & CLEAR; DABAO; JOHNSON’S Adult; LUBRIDERM; NEUTROGENA; RoC; and VENDÔME product lines. Brands in the Oral Care franchise include the LISTERINE oral care lines. The Wound Care franchise includes BAND-AID Brand Adhesive Bandages and NEOSPORIN First Aid products. Major brands in the Women’s Health franchise outside of North America are STAYFREE and CAREFREE sanitary pad and o.b. tampon brands. The principal nutritional line is SPLENDA No Calorie Sweetener. Over-the-counter medicines include a family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; ZYRTEC allergy products; MOTRIN IB ibuprofen products; and PEPCID line of heartburn products. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. Pharmaceutical The Pharmaceutical segment includes products in the following areas: anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management and vaccines. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use. Main products in the Pharmaceutical segment include REMICADE (infliximab), a treatment for immune-mediated inflammatory diseases; SIMPONI (golimumab), a treatment for adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis and moderately active to severely active ulcerative colitis; STELARA (ustekinumab), a treatment for adults with moderate to severe plaque psoriasis and active psoriatic arthritis; INCIVO (telaprevir), for the treatment of hepatitis C; INTELENCE (etravirine) and PREZISTA (darunavir), treatments for HIV/AIDS; CONCERTA (methylphenidate HCl) extended-release tablets CII, a treatment for attention deficit hyperactivity disorder; INVEGA (paliperidone) extended-release tablets, for the treatment of schizophrenia and schizoaffective disorder; INVEGA SUSTENNA/XEPLION (paliperidone palmitate), for the treatment of schizophrenia in adults; RISPERDAL CONSTA (risperidone), for the treatment of schizophrenia and for the maintenance treatment of Bipolar I Disorder; VELCADE (bortezomib), a treatment for multiple myeloma; ZYTIGA (abiraterone acetate), a treatment for metastatic castration-resistant prostate cancer; ACIPHEX/PARIET, a proton pump inhibitor co-marketed with Eisai Inc.; PROCRIT (epoetin alfa, sold outside the U.S. as EPREX), to stimulate red blood cell production; and XARELTO (rivaroxaban), an oral anticoagulant for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing hip or knee replacement surgery, to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the treatment of DVT and PE, and for the reduction in the risk of recurrence of DVT and PE. Medical Devices and Diagnostics The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $106.74 USD +1.19

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $25.71 USD +0.09
Intel Corp $37.21 USD +0.84
International Business Machines Corp $161.44 USD +2.93
Pfizer Inc $32.09 USD +0.15
Procter & Gamble Co/The $92.60 USD +0.55
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 17.5x
Price/Sales 4.0x
Price/Book 3.9x
Price/Cash Flow 17.1x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.